Skip to main content
Equibles
ADUS logo

ADUS · Addus HomeCare Corp · Metrics

Track ADUS — free

Use ADUS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$117.60 -1.72 (-1.44%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.22B
Shares
18.67M

ADUS metrics

82 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$119.32
Market cap
$2.22B

Price action

20 metrics
Price change (1W)
+2.8%
Price change (30D)
-0.5%
Price change (3M)
+28.9%
Price change (6M)
+15.1%
Price change (YTD)
+10.6%
Price change (1Y)
+6.2%
Trailing year
Price change (5Y)
+31.6%
52-week high
$122.75
52-week low
$88.49
Change from 52-week high
-3.3%
Change from 52-week low
+34.2%
Annualized volatility
29.3%
Annualized volatility (3M)
24.2%
Beta
0.3
RSI (14D)
56.1
Price vs SMA 50
+4.3%
Price vs SMA 200
+12.4%
Avg volume (3M)
233,765
Relative volume
0.8
Average dollar volume
$25.44M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
18.67M

Valuation

12 metrics
P / E (TTM)
20.8
Trailing earnings · reciprocal yield 4.8%
PEG ratio
0.9
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 66.6%
P / book
1.9
reciprocal yield 51.8%
FCF yield
7.0%
TTM · current market cap
Buyback yield
—
P / FCF
14.3
reciprocal yield 7.0%
P / operating cash flow
13.7
reciprocal yield 7.3%
Earnings yield
4.7%

Historical valuation

8 metrics
P / E historical average (3Y)
23.8×
reciprocal yield 4.2%
P / E historical average (5Y)
28.1×
reciprocal yield 3.6%
EV / revenue historical average (3Y)
1.7×
reciprocal yield 59.0%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 55.5%
EV / EBIT historical average (3Y)
21.2×
reciprocal yield 4.7%
EV / EBIT historical average (5Y)
25.1×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
17.9×
reciprocal yield 5.6%
EV / EBITDA historical average (5Y)
20.6×
reciprocal yield 4.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
32.4%
Operating margin
10.0%
Trailing 12 months
Net margin
7.1%
Gross profit (TTM)
$477.75M
Operating profit (TTM)
$148.23M
Net income (TTM)
$105.31M
Trailing 12 months
Diluted EPS (TTM)
$5.71
FCF margin
10.5%
Effective tax rate
25.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$8.19

Growth

11 metrics
Revenue growth YoY
+8.0%
Year over year
Net income growth YoY
+25.2%
Revenue (TTM)
$1.48B
Trailing 12 months
EPS growth YoY
+24.2%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+14.4%
Revenue CAGR (5Y)
+13.2%
EPS CAGR (3Y)
+22.5%
EPS CAGR (5Y)
+20.2%
FCF CAGR (3Y)
+2.3%
FCF CAGR (5Y)
+0.2%

Quality

14 metrics
Return on equity
9.2%
Return on assets
7.2%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$164.94M
Free cash flow (TTM)
$154.77M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$96.95M
Total assets
$1.46B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$162.41M
Capital expenditures (TTM)
$7.63M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$18.22M
R&D / revenue
—
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
304
13F filer change QoQ
+6
Institutional ownership
104.1%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$27,006
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1468328 CUSIP 006739106 13F (30d) 176 filings 176 filers Visit website Investor relations